Company Overview - scCO2 Sterilization Solutions
NovaSterilis: Improving patient outcomes through the use of supercritical CO2 solutions in medical devices and materials.
At its core, NovaSterilis is a team of intelligent, caring, and demanding scientists, engineers, and businesspeople committed to meeting customer needs through problem solving and Supercritical CO2 solutions. We have readily available equipment and process solutions for defined customer needs, and we can provide contract research services when the customer’s needs present unique requirements.
Our team of multi-disciplinary engineers, biochemists, molecular and cellular biologists bring a breadth of knowledge and experience to every product development and research challenge. Our vision is to improve people’s lives by offering solutions that increase product safety and create better outcomes for end users.
Achieve Sterility Assurance Level 10-6
Supercritical CO2 is the deepest penetrating sterilization modality and achieves a SAL 10-6 for medical devices.
Eco-friendly Alternative to EO
Supercritical CO2 is less expensive then EO when comparing operating costs and is broadly compatible with biomaterials – all while offering a sterilization solution to regulatory pressures presented by the FDA and EPA.
Broader Compatibility, including Biologics
Supercritical CO2 is broadly compatible with a range of materials including medical devices and biologics.
Quick Facts
- Headquarters: Lansing, NY
- Capabilities: Deep expertise in providing Supercritical CO2 Sterilization solutions including contract research and equipment.
- Markets: Globally-servicing Regenerative Medicine, Medicine Devices, R&D-Life Sciences, Biotherapeutics, Additive Manufacturing, and Pharma industries.
- Founded: NovaSterilis was launched in 2001 to commercialize a broad range of emerging combination products that required gentle, low-temperature sterilization, and by 2006 our effective, safe, and commercially viable scCO2 terminal sterilization process was developed.